The Latest Cardiac and Vascular News
IRVINE, Calif., Dec. 20, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe pulmonary regurgitation. The Edwards SAPIEN 3 […]
CALGARY, AB, Dec. 20, 2021 /PRNewswire/ – Canadian Pacific (CP) is proud to announce that fundraising efforts over the past two years for the CP Women’s Open (CPWO) have helped raise more than $2.8 million to support important equipment purchases and research at BC Children’s Hospital, along with an additional $557,000 for Kamloops Royal Inland Hospital. […]
MOUNTAIN VIEW, Calif., Dec. 20, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that KardiaMobile 6L, the most clinically-validated six-lead personal ECG device, is now available via KardiaPro on Epic’s App Orchard Marketplace for hospitals, health systems and providers. The integration will enable even more healthcare […]
JI XING to Develop and Commercialize Novel Cardiac Myosin Activator in Patients with Heart Failure Cytokinetics to Receive $70 Million in Committed Capital; Up to an Additional $330 Million in Potential Milestone Payments Plus Royalties Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time SOUTH SAN […]
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma Partners Investment will fund clinical studies of ARMGO’s lead molecule ARM210, an oral treatment, in development for cardiac and skeletal […]
Acarix AB (“Acarix” or the “Company”) has completed the new share issue of a maximum of 105 784 311 shares with preferential rights for the Company’s existing shareholders, which was resolved by the extra general meeting on 23 November 2021 (the “Rights Issue”). Acarix today announces the final outcome of […]
Quantification of the structure and composition of the vessel wall and assessment of lipid-rich necrotic core plaque (CPT 0710T-0713T) BOSTON–(BUSINESS WIRE)–Elucid, a Boston-based medical technology company harnessing scientific imaging and artificial intelligence to enable the precise diagnosis and treatment of the world’s leading cause of death announced a new CPT […]
Company Achieves Key Milestone in the Development of Its Next Generation Deep Venous Stent System WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced the completion of enrollment in its pivotal study – Venous stent for the Iliofemoral Vein Investigational clinical trial using the Vesper DUO Venous Stent […]
SAN RAFAEL, Calif. and SHANGHAI, Dec. 16, 2021 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, today announced a multi-year global strategic collaboration for the discovery, development and commercialization of Adeno-Associated Virus (AAV) gene therapies to […]
NORRISTOWN, Pa.–(BUSINESS WIRE)–Thubrikar Aortic Valve, Inc., announced today that it received approval from a Competent Authority in Poland to conduct initial patient implants with its Optimum Transcatheter Aortic Valve Implantation (TAVI) system™. The Company will sponsor this CE Mark-enabling pilot study on patients with severe Aortic Stenosis and begin to […]
